Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...
Acella announced the approval of an Abbreviated New Drug Application (ANDA) for Tranexamic Acid Injection 1000mg/10mL, the generic version of Pfizer’s Cyklokapron. Cyklokapron is a plasminogen ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid Injection, USP in ...
The UK's cost containment agency, the National Institute for health and Clinical Excellence (NICE), has published supporting evidence for the off-label use of Pfizer's Cyklokapronby the National ...
Avenacy's tranexamic acid injection is available in 1,000 mg/10 ml (100 mg per ml) 10-pack single-dose vials. In line with Avenacy’s mission to champion patient safety and streamline patient care, ...